Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (BCC): 24-month update of the pivotal ERIVANCE BCC study A Sekulic,1 MR Migden,2 AE Oro,3 L Dirix,4 K Lewis,5 JD Hainsworth,6

First Page		Document Content
Date: 2014-05-12 19:51:02 Histopathology End point of clinical trials Response Evaluation Criteria in Solid Tumors Vismodegib Medicine Basal-cell carcinoma Carcinoma		Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma (BCC): 24-month update of the pivotal ERIVANCE BCC study A Sekulic,1 MR Migden,2 AE Oro,3 L Dirix,4 K Lewis,5 JD Hainsworth,6 Add to Reading List Source URL: www.curis.com Download Document from Source Website File Size: 321,96 KB Share Document on Facebook

	CMTF005 - Food is Medicine - Checklist_Debranded DocID: 1xVMk - View Document
	Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses Daniel Halperin† Thomas S. Heydt-Benjamin† DocID: 1xVge - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_with bleed DocID: 1xUza - View Document
	CMTF005 - Food is Medicine - Checklist_Debranded_edited DocID: 1xTtU - View Document
	PDF Document DocID: 1xSqy - View Document